| Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts N Ferrari, R Ranftl, I Chicherova, ND Slaven, E Moeendarbary, ... Nature communications 10 (1), 130, 2019 | 134 | 2019 |
| Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study M Pedersen, MCW Westergaard, K Milne, M Nielsen, TH Borch, ... Oncoimmunology 7 (12), e1502905, 2018 | 94 | 2018 |
| Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation J Duraiswamy, R Turrini, A Minasyan, D Barras, I Crespo, AJ Grimm, ... Cancer Cell 39 (12), 1623-1642. e20, 2021 | 83 | 2021 |
| Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer AH Kverneland, M Pedersen, MCW Westergaard, M Nielsen, TH Borch, ... Oncotarget 11 (22), 2092, 2020 | 82 | 2020 |
| Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma R Andersen, M Donia, MCW Westergaard, M Pedersen, M Hansen, ... Human vaccines & immunotherapeutics 11 (12), 2790-2795, 2015 | 79 | 2015 |
| T-cell responses in the microenvironment of primary renal cell carcinoma—implications for adoptive cell therapy R Andersen, MCW Westergaard, JW Kjeldsen, A Müller, NW Pedersen, ... Cancer immunology research 6 (2), 222-235, 2018 | 78* | 2018 |
| CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment E Martinenaite, S Munir Ahmad, M Hansen, Ö Met, MW Westergaard, ... Oncoimmunology 5 (11), e1238541, 2016 | 76 | 2016 |
| CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer C Friese, K Harbst, TH Borch, MCW Westergaard, M Pedersen, ... Scientific reports 10 (1), 3914, 2020 | 67 | 2020 |
| T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression R Andersen, TH Borch, A Draghi, A Gokuldass, MAH Rana, M Pedersen, ... Annals of Oncology 29 (7), 1575-1581, 2018 | 67 | 2018 |
| PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer M Donia, JW Kjeldsen, R Andersen, MCW Westergaard, V Bianchi, ... Clinical Cancer Research 23 (19), 5779-5788, 2017 | 57 | 2017 |
| Tumour-reactive T cell subsets in the microenvironment of ovarian cancer MCW Westergaard, R Andersen, C Chong, JW Kjeldsen, M Pedersen, ... British journal of cancer 120 (4), 424-434, 2019 | 56 | 2019 |
| Elevated concentrations of serum immunoglobulin free light chains in systemic lupus erythematosus patients in relation to disease activity, inflammatory status, B cell activity … AH Draborg, MC Lydolph, M Westergaard, S Olesen Larsen, CT Nielsen, ... PloS one 10 (9), e0138753, 2015 | 53* | 2015 |
| Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients AH Draborg, S Jacobsen, M Westergaard, S Mortensen, JL Larsen, ... Lupus science & medicine 1 (1), e000015, 2014 | 52 | 2014 |
| Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies MW Westergaard, AH Draborg, L Troelsen, S Jacobsen, G Houen BioMed research international 2015, 2015 | 43 | 2015 |
| Changes in the tumor immune microenvironment during disease progression in patients with ovarian cancer MCW Westergaard, K Milne, M Pedersen, T Hasselager, LR Olsen, ... Cancers 12 (12), 3828, 2020 | 25 | 2020 |
| Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF® 09b, in patients with metastatic melanoma SK Mørk, M Kadivar, KF Bol, A Draghi, MCW Westergaard, SK Skadborg, ... Oncoimmunology 11 (1), 2023255, 2022 | 23 | 2022 |
| Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma … A Gokuldass, A Draghi, K Papp, TH Borch, M Nielsen, MCW Westergaard, ... Cancers 12 (11), 3344, 2020 | 23 | 2020 |
| In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes M Nielsen, A Krarup-Hansen, D Hovgaard, MM Petersen, AC Loya, ... Cancer Immunology, Immunotherapy 69, 2179-2191, 2020 | 20 | 2020 |
| Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor … A Draghi, CA Chamberlain, S Khan, K Papp, M Lauss, S Soraggi, ... Frontiers in Immunology 12, 705422, 2021 | 15 | 2021 |
| The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro M Presti, MCW Westergaard, A Draghi, CA Chamberlain, A Gokuldass, ... Cancer Immunology, Immunotherapy 70, 1771-1776, 2021 | 10 | 2021 |
